GSK Investigational Site

Humenné 066 01

0 studies enrolling now · 2 studies all time

What they study most

Pulmonary Disease, Chronic Obstructive

Studies at this site

• Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD — Completed